Shares of biotech micro-cap Cyclacel Pharmaceuticals (CYCC) have doubled in price in the past 10 days. Call it the Lloyd Christmas effect.
Dumb & Dumber.
You can sort of understand why momentum traders would be attracted to a penny biotech stock like Cyclacel. It recently underwent a 1-for-12 reverse split, taking the share count down to 3 million. It's a low floater.
Dumb & Dumber.
You can sort of understand why momentum traders would be attracted to a penny biotech stock like Cyclacel. It recently underwent a 1-for-12 reverse split, taking the share count down to 3 million. It's a low floater.
